| Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder M Heidari, M Zarei, SMR Hosseini, R Taghvaei, H Maleki, M Tabrizi, ... International clinical psychopharmacology 29 (6), 344-350, 2014 | 58 | 2014 |
| 18 normal patterns of regional brain f-fdg uptake in normal aging SP Shamchi, M Khosravi, R Taghvaei, MK Paydary, MS Emamzadehfard, ... Hellenic journal of nuclear medicine 21 (3), 175-180, 2018 | 22 | 2018 |
| COVID-19-associated encephalopathy with fulminant cerebral vasoconstriction: CT and MRI findings R Sirous, R Taghvaei, JC Hellinger, AV Krauthamer, S Mirfendereski Radiology Case Reports 15 (11), 2208-2212, 2020 | 10 | 2020 |
| Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy R Taghvaei, MZ Zadeh, R Sirous, SP Shamchi, WY Raynor, SM Seraj, ... American Journal of Nuclear Medicine and Molecular Imaging 8 (6), 407, 2018 | 10 | 2018 |
| Critical role of PET/CT-based novel quantitative techniques for assessing global disease activity in multiple myeloma and other hematological malignancies: why it is time to … R Taghvaei, MZ Zadeh, TJ Werner, A Alavi European Radiology 31, 149-151, 2021 | 8 | 2021 |
| Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation SP Shamchi, MZ Zadeh, B Østergaard, J Kim, WY Raynor, M Khosravi, ... Nuclear Medicine Communications 41 (3), 288-293, 2020 | 7 | 2020 |
| The relationship between anthropometric indices and breast cancer in central Iran R Taleban, R Sirous, M Sirous, S Razavi, R Taghvaei, S Sirous, ... Nutrition and cancer 71 (8), 1276-1282, 2019 | 7 | 2019 |
| Correlation of dual time point FDG-PET with response to chemotherapy in multiple myeloma R Taghvaei, B Oestergaard, MZ Zadeh, W Raynor, K Paydary, ... Journal of Nuclear Medicine 58 (supplement 1), 188-188, 2017 | 7 | 2017 |
| Changes in bone marrow FDG uptake in multiple myeloma patients before and after treatment. MZ Zadeh, W Raynor, B Oestergaard, R Taghvaei, O Acosta-Montenegro, ... Journal of Nuclear Medicine 59 (supplement 1), 1430-1430, 2018 | 6 | 2018 |
| Alteration of normal regional brain FDG uptake in normal aging SP Shamchi, M Khosravi, R Taghvaei, S Emamzadehfard, K Paydary, ... Journal of Nuclear Medicine 58 (supplement 1), 483-483, 2017 | 6 | 2017 |
| Assessing coronary artery and aortic calcification in patients with prostate cancer using 18F-Sodium Fluoride PET/computed tomography WY Raynor, AJ Borja, V Zhang, E Kothekar, HC Lau, SJ Ng, SM Seraj, ... PET clinics 17 (4), 653-659, 2022 | 4 | 2022 |
| Quantification of the total bone marrow activity with FDG-PET in multiple myeloma before and after treatment: comparison with a control group. MZ Zadeh, B Oestergaard, W Raynor, R Taghvaei, O Acosta-Montenegro, ... Journal of Nuclear Medicine 58 (supplement 1), 190-190, 2017 | 4 | 2017 |
| Global assessment of PET tracer uptake in the skeleton using CT segmentation: a novel approach to quantification of disease activity and whole body metabolism. O Acosta-Montenegro, W Raynor, C Ayubcha, SP Shamchi, M Khosravi, ... Journal of Nuclear Medicine 58 (supplement 1), 1017-1017, 2017 | 4 | 2017 |
| Feasibility of using global FDG uptake in bone marrow to assess treatment of multiple myeloma. O Acosta-Montenegro, W Raynor, B Oestergaard, MZ Zadeh, R Taghvaei, ... Journal of Nuclear Medicine 58 (supplement 1), 189-189, 2017 | 2 | 2017 |
| PET imaging in hematological malignancies R Taghvaei, MZ Zadeh, B Oestergaard, W Raynor, SP Shamchi, ... Journal of Nuclear Medicine 58 (supplement 1), 1008-1008, 2017 | 2 | 2017 |
| Applications of FDG-and NaF-PET in musculoskeletal disorders W Raynor, A Gholamrezanezhad, S Hess, A Borja, SM Seraj, D Detchou, ... Journal of Nuclear Medicine 62 (supplement 1), 2004-2004, 2021 | 1 | 2021 |
| Role of FDG in the management of radiation-induced complications in patients with head and neck malignancies E Hancin, A Borja, A Mouminah, R Taghvaei, B Koa, KV Rojulpote, ... Journal of Nuclear Medicine 61 (supplement 1), 1185-1185, 2020 | 1 | 2020 |
| Utilizing FDG-PET/CT to assess radiation-induced cardiotoxicity in patients with lung cancer based on tumor location R Taghvaei, R Sirous, A Dreyfuss, T Werner, A Alavi Journal of Nuclear Medicine 60 (supplement 1), 1314-1314, 2019 | 1 | 2019 |
| Assessment of uptake of FDG in the whole bone marrow of multiple myeloma and smoldering multiple myeloma patients through a novel method of PET/CT quantification: comparison … MZ Zadeh, B Ostergaard, W Raynor, C Ayubcha, O Acosta-Montenegro, ... Journal of Nuclear Medicine 60 (supplement 1), 143-143, 2019 | 1 | 2019 |
| Assessment of bone turnover in multiple myeloma patients before and after treatment. MZ Zadeh, W Raynor, B Oestergaard, R Taghvaei, O Acosta-Montenegro, ... Journal of Nuclear Medicine 59 (supplement 1), 1429-1429, 2018 | 1 | 2018 |
Abass AlaviUPENNVerified email at uphs.upenn.edu
